Reliable Costing Over Time

How life care planning methodology develops reliable future medical cost estimates over time.

ATTORNEY QUESTION

“If Medicare or insurance would pay less, why isn’t that the future medical cost?”

This is one of the most common questions attorneys encounter in future medical damages. It arises in deposition, mediation, settlement discussions, and trial because future medical costing is often confused with reimbursement.

The confusion usually begins with a familiar question: What will the provider accept as payment? That may be an important reimbursement question. It is not, however, the same question answered by a life care plan. Life care planning asks a different question: What will it reasonably cost to obtain the medically necessary care over time?

The Short Answer

Life care planning methodology is designed to develop reliable estimates of the anticipated cost of medically necessary future care over time. To accomplish that objective, the methodology uses pricing sources that are appropriate for the care being projected rather than assuming a particular reimbursement system, insurance plan, or benefit structure will remain unchanged throughout the duration of the life care plan.

Future coverage, eligibility, provider networks, contracts, and payment rules may all change over time. By focusing on the anticipated cost of obtaining recommended care, the methodology provides a consistent framework that remains applicable despite those changes.

Medicare and negotiated insurance rates may be relevant in certain legal contexts, but they are reimbursement mechanisms. They are not designed to estimate the market cost of obtaining future medical care over the duration of the life care plan.

Medicare Illustrates the Difference

Medicare answers a reimbursement question: What would Medicare reimburse under Medicare rules? Those rules are shaped by federal policy, coverage requirements, coding rules, and payment schedules.

A life care plan answers a different question: What is the anticipated cost of obtaining the medically necessary care that has been recommended?

Those questions may overlap in certain situations, but they should not be treated as interchangeable. Medicare eligibility may change. Coverage may not apply to every recommended service, provider, frequency, product, or setting. The life care planning methodology is designed to remain reliable despite those variables.

FUTURE MEDICAL COSTING

Maintaining Reliable Costing Over Time

A life care plan is intended to remain reliable over the duration of the plan. Because reimbursement systems, insurance coverage, provider networks, eligibility, and payment rules may change over time, the methodology focuses on the anticipated cost of obtaining medically necessary care rather than predicting which payer or reimbursement structure may apply years or decades into the future.

If a legal venue requires collateral-source or reimbursement analyses, those issues can be addressed separately. They should not be confused with the methodology used to develop future medical cost estimates.

Why This Matters in Practice

When evaluating a future medical cost opinion, attorneys should ask:

Keeping those questions separate helps ensure that future medical costing remains focused on the methodology used to estimate anticipated care costs, while reimbursement issues are evaluated within their own legal context.

Bottom Line

Life care planning methodology is designed to develop reliable estimates of the anticipated cost of medically necessary future care over time. Medicare and insurance reimbursement may be relevant in certain legal contexts, but they answer a different question than the methodology used to estimate future medical costs.

Read Part 3 in this series →

Meet the Expert

Dr. Ashea Neil, OTD, OTR/L, CLCP
Doctor of Occupational Therapy | Certified Life Care Planner | Certified Work Capacity Evaluator | Certified Vocational Evaluator

Ashea Neil Turning Point Life Care Planning

Why Percentiles Matter

Understanding Market-Based Pricing

ATTORNEY QUESTION

“Why did the expert use the 75th or 80th percentile instead of the 50th?”

Percentiles can become a distraction in future medical cost disputes. A life care plan may refer to the 75th or 80th percentile, and an opposing expert may represent that the 50th percentile sounds more reasonable because it is “average.” But that comparison oversimplifies the issue.

The 50th percentile is the median. It is not automatically the average, and it is not automatically the most representative measure of what future care will cost. In healthcare pricing, charges are often uneven. Charges often cluster within one range, while a smaller number extend into a higher-cost range. That type of distribution can make the midpoint less useful than it appears.

The Short Answer

Percentiles matter because healthcare charges are not always normally distributed. Published healthcare pricing references use percentile-based analyses because market charges are not uniformly distributed. UCR-based pricing commonly uses percentile data to help identify a market-based charge for comparable care in a relevant geographic area.

UCR means usual, customary, and reasonable. In future medical costing, UCR is generally used to describe market-based charge information. It is not the same as asking what Medicare will pay. It is not the same as asking what a private insurer negotiated. It is not the same as asking what a provider accepted from a particular payer on a past bill.

That distinction matters because UCR is aimed at market-based charges, while reimbursement data is shaped by payer rules and contractual arrangements.

Why the 50th Percentile Can Be Misleading

The phrase “50th percentile” often sounds intuitively reasonable. But intuition is not always accuracy. If healthcare charges are skewed, the midpoint may not reflect the practical cost of obtaining care. That is why published life care planning and healthcare pricing sources commonly discuss UCR in the 75th to 80th percentile range when the data, service, geography, and context support it.

A higher percentile is not always correct. The appropriate percentile depends on the source and the purpose of the opinion. This distinction also helps avoid a common misunderstanding: using different pricing tools does not mean using different methodologies. A life care planner may use UCR-oriented data for certain medical services and vendor surveys for services such as therapy, equipment, or home modifications. The methodology remains consistent because the same analytical question is being asked: what source best reflects the anticipated cost of obtaining this particular care?

the 50th Percentile

Question Being Asked
Type Of Data That May Respond
Why It Matters”
What do comparable providers charge in this market?
UCR / market-charge data
Addresses market-based cost
What would Medicare reimburse?
Medicare fee schedule
Addresses government reimbursement
What did this insurer allow under this plan?
Paid / allowed data
Addresses a specific payer contract or claim
What is the current local cost for this item or service?
Vendor quote or survey
Addresses specific local availability and pricing

What UCR Is—and What It Is Not

UCR is intended to help estimate what comparable providers in a geographic market commonly charge for a service. It is a market-based concept. It is used because the life care planning question is forward-looking: what will it reasonably cost to obtain the care?

UCR is not a promise that a provider will accept a particular amount as payment in full. It is not an insurance contract. It is not Medicare. It is not a negotiated rate. Those figures may be relevant in some legal or factual contexts, but they answer different questions.

Why This Matters in Practice

When evaluating a future medical cost opinion, the issue should not be reduced to: “Why not use the lower number?” A different number can almost always be found somewhere. The better question is: what does that number represent?

A Medicare figure represents Medicare reimbursement. A negotiated rate represents a contract-based allowance. A UCR percentile represents market-charge data. These numbers may all be discussed in a case, but they are not interchangeable.

For attorneys, the practical takeaway is to separate the pricing question before debating the number. If the issue is the future cost of obtaining care, a market-based UCR analysis may answer a different question than a past paid amount or reimbursement schedule.

Bottom Line

The 50th percentile is not automatically the “average” future cost. UCR is market-based pricing, not payer acceptance or contractual reimbursement.

Meet the Expert

Dr. Ashea Neil, OTD, OTR/L, CLCP
Doctor of Occupational Therapy | Certified Life Care Planner | Certified Work Capacity Evaluator | Certified Vocational Evaluator

Ashea Neil Turning Point Life Care Planning

Future Medical Costs

How Are Future Medical Costs Determined?

ATTORNEY QUESTION

“How did you determine those costs?”

Future medical costing is often challenged because the projected dollar amount appears, at first glance, to be the most important part of the opinion. Yet the more important question is not whether the number is high or low, but how it was developed.

In life care planning, future medical costing is not the same exercise as reviewing past medical bills. A past bill review may focus on what was billed, what was adjusted, what was allowed, and what was actually paid. Those questions can matter in the right context. But a life care plan asks a forward-looking question: what care is expected to be needed, and what will it reasonably cost to obtain that care over time?

Past payment data looks backward at a particular transaction, payer, contract, or benefit structure. Future medical costing looks forward at anticipated care needs, changing coverage, provider availability, and the practical cost of obtaining medically necessary services over time.

The Short Answer

Future medical costs are determined through a structured, published costing methodology. Published life care planning literature describes a methodology for selecting pricing sources that are appropriate for the care being projected, rather than relying on a single reimbursement schedule or payment history. The methodology does not require every future item to be priced with the same tool. Instead, it requires the pricing source to fit the service being projected.

This is not a contradiction. It is the point of a reliable costing analysis. A surgical procedure, a physician visit, a diagnostic study, outpatient therapy, durable medical equipment, home care, and home modifications are not all priced in the real world in the same way. A sound methodology recognizes those differences. The cost opinion should be anchored to the future care recommendation and matched to a pricing source that reasonably reflects that category of care.

What the Methodology Is Really Doing

The purpose of the methodology is to provide a consistent and transparent framework for translating future care recommendations into defensible cost opinions. For attorneys, the methodology can be understood in three practical steps:

Type of Pricing Source
Often Used For
Purpose
UCR / market-charge data
Code-driven medical services and geographically relevant market pricing
Helps estimate the market-based cost of comparable care
Vendor surveys / provider quotes
Therapy, durable medical equipment, home services, modifications, and specialized items
Useful when a generalized fee source may not reflect the actual cost of a community-based service
Medicare fee schedules
Reimbursement comparisons or legally required scenarios
Shows a payment methodology, not automatically the future cost of care
Paid / allowed amounts
Past bill review, claims history, or payer-specific context
Reflects a payer or contract event, not necessarily future cost

This distinction also helps avoid a common misunderstanding: using different pricing tools does not mean using different methodologies. A life care planner may use UCR-oriented data for certain medical services and vendor surveys for services such as therapy, equipment, or home modifications. The methodology remains consistent because the same analytical question is being asked: what source best reflects the anticipated cost of obtaining this particular care?

Future Medical Costs in Life Care Planning

Bottom Line

The published methodology is not “use one pricing source for everything.” It is to use a consistent framework and match the pricing tool to the care being projected.

Read Part 2 in this series →

Meet the Expert

Dr. Ashea Neil, OTD, OTR/L, CLCP
Doctor of Occupational Therapy | Certified Life Care Planner | Certified Work Capacity Evaluator | Certified Vocational Evaluator

Ashea Neil Turning Point Life Care Planning